Obinutuzumab, labeled as GA101, represents the novel monoclonal antibody designed for treat chronic lymphocytic leukemia. It targets this surface antigen expressed on B cells, leading to antibody-dependent https://www.targetmol.com/compound/obinutuzumab
Obinutuzumab (GA101): A Comprehensive Overview
Internet - 4 hours ago 949142-50-1484431Web Directory Categories
Web Directory Search
New Site Listings